Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
- Status
- COMPLETED
- Phase
- NA
Combined Therapy for Hepatocellular Carcinoma >3-<5 cm
- Status
- COMPLETED
- Phase
- NA
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE3
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules
- Status
- COMPLETED
- Phase
- N/A
Sorafenib or Lenvatinib Plus HAIC of 130 mg/m² Oxaliplatin, and 5-fu vs Sorafenib or Lenvatinib Plus HAIC of 85mg/m² Oxaliplatin, and 5-fu for Unresectable Advanced HCC: a Randomised Phase 3 Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phenotyping Liver Cancer Registry
- Status
- COMPLETED
- Phase
- N/A
Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational Study
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
- Status
- COMPLETED
- Phase
- PHASE1
HAIC of Oxaliplatin, and 2400 mg/m² 5-fu vs HAIC of Oxaliplatin, and 1200 mg/m² 5-fu for Unresectable HCC: a Randomised Phase 3 Non-inferiority Trial
- Status
- UNKNOWN
- Phase
- PHASE3
Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
- Status
- UNKNOWN
- Phase
- PHASE3